Swiss National Bank
AGN

Swiss National Bank’s Allergan Inc AGN Stock Holding History

Swiss National Bank’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-275,743
Closed -$58.6M – 2581
2014
Q4 		$58.6M Sell
275,743
-9,800
-3% -$1.95M 0.22% 111
2014
Q3 		$50.9M Sell
285,543
-5,400
-2% -$897K 0.2% 125
2014
Q2 		$49.2M Sell
290,943
-183,621
-39% -$28.6M 0.18% 137
2014
Q1 		$58.9M Sell
474,564
-22,000
-4% -$2.68M 0.23% 103
2013
Q4 		$55.2M Sell
496,564
-6,500
-1% -$621K 0.22% 117
2013
Q3 		$45.5M Buy
503,064
+6,600
+1% +$592K 0.19% 135
2013
Q2 		$41.8M Buy
+496,464
New +$51.5M 0.18% 135

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Swiss National Bank's AGN Position: Q1 2015 in Review

Swiss National Bank sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 275,743 shares — an estimated $58.6M sold.

Swiss National Bank first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $58.9M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Swiss National Bank reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Swiss National Bank sold 275,743 Allergan Inc shares in Q1 2015, an estimated $58.6M.
  • Swiss National Bank first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Swiss National Bank's Allergan Inc position peaked at $58.9M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.